Table: Fuji Pharmaceutical - 9-MTH group results

Fuji Pharma

05/08/2022 09:00

Aug 5 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Sep 30, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             26.47               25.50            35.97    
                 (+3.8 pct)          (+2.4 pct)       (+10.2 pct) 
  Operating          3.61                3.60             3.49    
                 (+0.3 pct)          (+62.0 pct)      (+4.2 pct)  
  Recurring          3.83                3.60             3.54    
                 (+6.2 pct)          (+67.6 pct)      (+8.9 pct)  
  Net                2.64                2.64             2.56    
                 (+0.0 pct)          (+68.8 pct)      (+5.3 pct)  
  EPS            108.77 yen           95.24 yen       105.49 yen  
  Ann Div                             29.00 yen        32.00 yen  
  -Q2 div         15.00 yen           14.00 yen                   
  -Q4 div                             15.00 yen        17.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T